← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2010Last known activity
Apr 1, 2016
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 4 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT03825133Lead sponsorPhase 4Apr 1, 2016
- NCT03825133Reponsible party - principal investigatorPhase 4Apr 1, 2016
- NCT01972620Overall official - principal investigatorN/AFeb 1, 2010
Details
- Last known activity
- Apr 1, 2016